Inspiro Medical

Dry Powder Inhaler

Health Tech & Life Sciences
Acquired by OPKO Health
Acquired Ness Ziona, Israel Founded 2010
Last updated 2026-06-18
Total raised
Last: 2010-12
Stage
Acquired
Founded
2010
Headcount
6
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

Inspiro Medical is a medical device company dedicated to the development of an inhalation platform designed to deliver small molecules, such as corticosteroids or beta agonists, and macromolecules such as antibodies or vaccines. Inspiro Medical is developing Inspiromatic, a dry powder inhaler (DPI) that uses technology to overcome the drawbacks of current inhalers and ensure optimal drug delivery. The company's proprietary DPI combines an active dry powder fluidization mechanism that works at low-inhalation flow rates with a real-time feedback control and data logger indicating proper inhalation technique and follow-up. Young children and the elderly can particularly benefit from the advantages of Inspiro's dry powder inhalation solution.

Funding history · 1 round · — total

2010-12
Undisclosed

Q&A

What is Inspiro Medical's primary business?
Inspiro Medical is a medical device company focused on developing an inhalation platform for delivering small molecules, such as corticosteroids or beta agonists, and macromolecules like antibodies or vaccines.
What is Inspiro Medical's key product?
Inspiro Medical is developing Inspiromatic, a proprietary dry powder inhaler (DPI) that uses an active dry powder fluidization mechanism and real-time feedback control to ensure optimal drug delivery, even at low-inhalation flow rates.
When was Inspiro Medical founded?
Inspiro Medical was founded in November 2010.
Who acquired Inspiro Medical and when?
Inspiro Medical was acquired by OPKO Health in April 2014.
What is the current status of Inspiro Medical?
Inspiro Medical is currently inactive, having ceased to operate after its acquisition by OPKO Health in April 2014.
How many employees did Inspiro Medical have?
Inspiro Medical had 1-10 employees.
What type of customers does Inspiro Medical's technology target?
Inspiro Medical's dry powder inhalation solution is particularly beneficial for young children and the elderly.
Which investor participated in Inspiro Medical's funding round in December 2010?
The Trendlines Group participated in Inspiro Medical's funding round in December 2010.

Team · 1

Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug Delivery
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsConsumersDemographics & FamilyChildrenSeniors
Business model
B2C

Highlights

1 Patents

Tags

asthmamedical-devicesinhalationdrug-deliverychildrenpulmonaryseniorsrespiratoryadherencepatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2010-11
Employees (exact)6
Status reasonAcquired (Inactive) by OPKO Health on Apr 2014 - ceased to operate

Acquisitions & public offerings

Acquired by OPKO Health 2014-04

Radar intelligence

Patents

EPO2